Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04488068 · ClinicalTrials.gov registry record · NA

Transpelvic Magnetic Stimulation to Improve Urogenital Function

A NA study of Prostate Cancer and Erectile Dysfunction, sponsored by VA Office of Research and Development.

Completed
Registry status
NA
Development phase
12
Enrollment target
1
Study location

NCT04488068 is a NA study of Prostate Cancer and Erectile Dysfunction that has completed, run by VA Office of Research and Development. The registered enrollment target is 12 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04488068, a NA study of Prostate Cancer and Erectile Dysfunction, has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
NA
Development phase
12 participants
Enrollment target
1
Study location

Study Summary

After recruitment, 20 male patients will be assigned 1:1 to either age-matched control (G1: sham) or age-matched intervention (G2: pelvic magnetic stimulation; TPMS) groups using computer-generated process, and baseline parameters will be established. All patients will be instructed by the investigators to perform standard of care pelvic floor exercise for the duration of the study. In addition, G2 patients will receive TPMS, while G1 patients will undergo sham treatment.

Interventions

  • PROCEDURE Sham Magnetic stimulation

Study Locations (1)

California

  • VA San Diego Healthcare System, San Diego, CA - San Diego

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2020-10-01
Est. Completion 2022-09-30
Phase NA

Sponsor

VA Office of Research and Development

1,668 total trials

What the Registry Record Tells You About NCT04488068

The ClinicalTrials.gov registry entry for NCT04488068 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (98% lower). The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Prostate Cancer appearing as the primary indexed condition, and to 1 intervention - of which Sham Magnetic stimulation is the first listed.

NCT04488068 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT04488068 about?

NCT04488068 is a clinical study titled "Transpelvic Magnetic Stimulation to Improve Urogenital Function". After recruitment, 20 male patients will be assigned 1:1 to either age-matched control (G1: sham) or age-matched intervention (G2: pelvic magnetic stimulation; TPMS) groups using computer-generated process, and baseline parameters will be established. All patients will be instructed by the investiga...

What is the current status of trial NCT04488068?

This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2020-10-01. Estimated completion is 2022-09-30.

What conditions does trial NCT04488068 study?

This clinical trial studies the following conditions: Prostate Cancer, Erectile Dysfunction.

What interventions are being tested in trial NCT04488068?

The interventions under investigation include: Sham Magnetic stimulation (PROCEDURE).

Who is sponsoring clinical trial NCT04488068?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04488068 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Prostate Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.